Your browser doesn't support javascript.
loading
Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy.
Hsu, Shu-Jung; Chao, Yen-Cheng; Lin, Xia-Hui; Liu, Hua-Hua; Zhang, Yang; Hong, Wei-Feng; Chen, Mao-Pei; Xu, Xin; Zhang, Lan; Ren, Zheng-Gang; Du, Shi-Suo; Chen, Rong-Xin.
Affiliation
  • Hsu SJ; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chao YC; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lin XH; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liu HH; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang Y; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hong WF; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen MP; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xu X; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang L; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ren ZG; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Du SS; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen RX; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Clin Exp Immunol ; 212(3): 239-248, 2023 06 05.
Article in En | MEDLINE | ID: mdl-36966354
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Immune System Diseases / Liver Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Immunol Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Immune System Diseases / Liver Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Immunol Year: 2023 Type: Article Affiliation country: China